/ASTH

Astrana Health Inc

ASTH

$37.98USD↓-0.13%-0.05 today

MARKET CAP

1.9B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$38 – $39

52W RANGE

$18

$52

AI Summary

Stalk

TrimMedium

ASTH is trading under the 9-day EMA, 20-day EMA, and 50-day SMA, signaling a medium-term bearish tradable side. Short-term momentum and sentiment show no clear edge, so execution should be deferred, with trimming into rallies toward the EMA zone and 50-day SMA.

↑Q2 revenue $972.5M (+49% YoY) and EPS $0.40 vs $0.19 last year.
↑Net income $19.7M (+110% YoY) with full-year revenue guide of $3.8–4.1B.
↓Negative profitability factors highlight margin conversion risks.

Full analysis →

Buying

4

institutions

Selling

9

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	6.90 M	320.23 M	+736.26 K	+111.9%	0.00%
3C 325 Capital LLC Q2 2026	SELL	1.61 M	74.90 M	+-225.23 K	+66.1%	17.85%
MM Millennium Management LLC Q2 2026	BUY	190.50 K	8.84 M	+174.91 K	+2213.1%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	74.65 K	3.46 M	+-29.90 K	+35.1%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	58.07 K	2.69 M	+-66.15 K	-11.5%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	49.62 K	2.31 M	+-6.57 K	+69.2%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	SELL	42.00 K	1.95 M	+-21.00 K	+26.2%	0.45%
JH Janus Henderson Group Plc Q1 2026	BUY	40.21 K	987.00 K	+20.11 K	+98.0%	0.00%
MG Man Group Plc Q2 2026	SELL	18.64 K	865.04 K	+-134.74 K	-77.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	17.63 K	818.12 K	+-16.75 K	-3.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	5.24 K	243.37 K	+1.57 K	+170.2%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-58.45 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-9.29 K	-100.0%	0.00%